Lactulose, a synthetic disaccharide derived from lactose, is garnering significant attention due to its prebiotic and therapeutic properties. Traditionally produced by alkaline isomerization ...

Cite this: Effect of Oral Lactulose on Clinical and Immunohistochemical Parameters in Patients with Inflammatory Bowel Disease: A Pilot Study - Medscape - Sep 04, 2007.

The aim of the present study was to investigate the clinical and histologic efficacy of lactulose in patients with IBD, for which probiotic therapy yielded promising results.

Cirrhosis, a chronic liver disease, progressively replaces healthy cells with scar tissue, impairing detoxification and ...

The global lactose and derivative market is forecasted to be valued at USD 43.83 billion in 2025 and is projected to rise at ...

Lactulose, as a prebiotic, can be utilized by human gut microbiota and stimulate their growth. Although microbiota modulation has become an emerging approach to manage many diseases and can be ...

The prevention and treatment of hepatic encephalopathy, in people with cirrhosis, largely depends on use of the compound lactulose. Rifaximin is not used to treat hepatic encephalopathy, at present, ...

Lactulose, a nondigestible disaccharide, is widely recognized for its significant health-promoting effects. The drawbacks of traditional chemical catalysis, e.g., high environmental pollution and ...

How Big Is The Global Laxatives Market Expected To Grow? The laxatives market is seeing formidable growth rates, with a projection to grow from $7.73 billion in 2024 to $8.39 billion in 2025 at a ...